|
|
|
Volumn 17, Issue 8, 2012, Pages 1-4
|
|
Comparing treatments for age-related macular degeneration: safety, effectiveness and cost.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
ARTICLE;
COMPARATIVE EFFECTIVENESS;
COST BENEFIT ANALYSIS;
DRUG APPROVAL;
DRUG EFFECT;
DRUG REPOSITIONING;
ECONOMICS;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
OFF LABEL DRUG USE;
PATIENT SAFETY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RETINA MACULA DEGENERATION;
TREATMENT OUTCOME;
UNITED STATES;
VISUAL ACUITY;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
COMPARATIVE EFFECTIVENESS RESEARCH;
COST-BENEFIT ANALYSIS;
DRUG APPROVAL;
DRUG REPOSITIONING;
HUMANS;
MACULAR DEGENERATION;
OFF-LABEL USE;
PATIENT SAFETY;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
|
|
EID: 84864025414
PISSN: None
EISSN: 15530671
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
